Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab (Q48453710)
Jump to navigation
Jump to search
scientific article published on 29 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab |
scientific article published on 29 June 2012 |
Statements
Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab (English)
Shasha Lv
Erik Teugels
Jan Sadones
Sylvia De Brakeleer
Stephanie Du Four